Authors
Latest:
The New Paradigm: Capturing Value, Improving Access, and Maximizing OutcomesQuality measures generate vital information on outcomes and can help ensure that medications are used appropriately and effectively.
Latest:
The Role of Specialty Drugs in Private Sector Healthcare SpendingThis study characterizes the role of specialty drug utilization in aggregate private sector healthcare spending in the United States from 2000 to 2009.
Latest:
Private-payer Costs for Employees with Treatment-resistant DepressionIndividuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
Latest:
Identification and Management of Recurrent C Difficile InfectionShared insight on the prevalence of recurring Clostridioides difficile infection and management strategies.
Latest:
Digital Tools Can Minimize GuessworkAutomation helps pharmacists increase their role in patient care by promoting adherence.
Latest:
Interoperability: Plugging Community Pharmacy into the Clinical Data SuperhighwayIn this age of emerging technology, it more important than ever for community pharmacists to get plugged into clinical data sharing.
Latest:
Leadership and Growth Opportunities for Clinical PharmacistsThe role of lead pharmacist provides a pathway to leadership.
Latest:
Easy Reading: Direct and Indirect Remuneration FeesHow a pharmacy performs with respect to specific measures can be associated with a DIR fee.
Latest:
Pharmacists Play Role in Pharmacogenomics Clinical ServicesThey should consider many factors and use clear guidance on predicting phenotypes from genotypes to intervene optimally based on specific drug-gene interactions.
Latest:
Predictive Analytics: A Case Study in Machine-Learning and Claims DatabasesA state-of-the-art predictive analysis tool that finds patients with rare diseases in a complex database could be valuable to stakeholders, who would achieve savings by helping physicians prescribe the appropriate treatment sooner.
Latest:
Cutting-Edge Heart Model Predicts Changes in the Heart That Can Lead to Atrial FibrillationA paper from a pair of physicists may reveal significant new information about the causes of atrial fibrillation and help to make cardiac ablations a more effective treatment for the condition.
Latest:
Alpha-Gal (Mammalian Meat) Allergy: Implications for PharmacistsAlpha-gal, a mammalian oligosaccharide, has recently been implicated in delayed anaphylaxis reactions to mammalian meat.
Latest:
Latent Tuberculosis After the Use of EtanerceptTNF-alpha inhibitors are used to treat a number of inflammatory conditions.
Latest:
Hepatitis C TreatmentThere are now 8 FDA approved medications for HCV treatment, all of which bypass the use of interferon.
Latest:
Patients with Advanced Cancer: Update on Pain ManagementDespite advances in pain management and palliative care, intractable cancer pain remains a significant clinical, social, and financial burden in treating the oncologic population.
Latest:
Conventional and Biologic Rheumatoid Arthritis Therapies: Utilization and Cost TrendsBased on American College of Rheumatology recommendations and novel emerging treatment options, the trend of increasing biologic use for rheumatoid arthritis is expected to continue.
Latest:
A Cultural Framework Is Essential in Patient CareRecognizing that culture is a multifaceted concept can lead to more careful and thoughtful use of the term.
Latest:
Antibiotics That Aggravate Myasthenia GravisMyasthenia gravis (MG) is an autoimmune-mediated neuromuscular disease characterized by muscle weakness.
